US HB1316 | 2011-2012 | 112th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 6-1)
Status: Introduced on April 1 2011 - 25% progression, died in committee
Action: 2011-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 1 2011 - 25% progression, died in committee
Action: 2011-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Stop Oxy Abuse Act of 2011 - Directs the Commissioner of Food and Drugs (FDA), within 90 days, to take such actions as may be necessary to modify the approval of, and limit any subsequent approval of, any drug containing controlled-release oxycodone hychloride to use for the relief of severe-only pain instead of moderate-to-severe pain. Applies any such modification to drugs introduced into interstate commerce 180 days after enactment of this Act.
Title
Stop Oxy Abuse Act of 2011
Sponsors
Rep. Mary Bono Mack [R-CA] | Rep. Vern Buchanan [R-FL] | Rep. Michael Fitzpatrick [R-PA] | Rep. Stephen Lynch [D-MA] |
Rep. Connie Mack [R-FL] | Rep. Harold Rogers [R-KY] | Rep. Frank Wolf [R-VA] |
History
Date | Chamber | Action |
---|---|---|
2011-04-07 | House | Referred to the Subcommittee on Health. |
2011-04-01 | House | Referred to the House Committee on Energy and Commerce. |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/112th-congress/house-bill/1316/all-info |
Text | https://www.congress.gov/112/bills/hr1316/BILLS-112hr1316ih.pdf |